Sanegene Bio is a Biotech company. It has raised $110M in total funding. Latest round: Series B. Backed by Sino Biopharm, Legend Capital, Vivo Capital.
Sanegene Bio is a Biotech company. Sanegene Bio has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2025. The round record for Sanegene Bio runs through 2025; nothing later has been disclosed. Investors on record include Sino Biopharm, Legend Capital, Vivo Capital, Invus, SymBiosis, Guofa Capital and 8 others. 14 distinct backers are named across the disclosed rounds.
Round data for Sanegene Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026